Metformin in dermatology: An overview

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 11, 2013, Pages 1329-1335

  Badr, D ^a   Kurban, M ^a   Abbas, O ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANDROGEN; ANDROSTENEDIONE; ANTIBIOTIC AGENT; B RAF KINASE; BIGUANIDE; CHOLESTEROL; CYPROTERONE ACETATE; CYPROTERONE ACETATE PLUS ETHINYLESTRADIOL; DIPEPTIDYL PEPTIDASE IV INHIBITOR; ETHINYLESTRADIOL; FLUTAMIDE; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR; ISOTRETINOIN; LUTEINIZING HORMONE; MELATONIN; MESSENGER RNA; METFORMIN; PHENFORMIN; PIOGLITAZONE; PLACEBO; PROTEIN BCL 2; ROSIGLITAZONE; SOMATOMEDIN; TESTOSTERONE; TRIACYLGLYCEROL; VASCULOTROPIN INHIBITOR;

ACANTHOSIS NIGRICANS; ACNE; ALOPECIA; ANOVULATION; ANTIPROLIFERATIVE ACTIVITY; BACTERIAL INFECTION; BODY MASS; BULLOUS PEMPHIGOID; CHEMOPROPHYLAXIS; DERMATITIS; DERMATOLOGY; DERMATOLOGY LIFE QUALITY INDEX; DESQUAMATION; DIABETES MELLITUS; DIAPHORESIS; DIARRHEA; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; ENDOCYTOSIS; FLATULENCE; FLUSHING; GENE MAPPING; GLUCOSE BLOOD LEVEL; HEART PALPITATION; HEARTBURN; HIRSUTISM; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; HYPERSENSITIVITY; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; IMPETIGO HERPETIFORMIS; INDIGESTION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULINEMIA; INTENSE PULSED LIGHT THERAPY; LACTIC ACIDOSIS; LEUKOCYTOCLASTIC VASCULITIS; LICHEN PLANUS; LOW BIRTH WEIGHT; MELANOMA; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MULTIPLE CYCLE TREATMENT; MYALGIA; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PATIENT SATISFACTION; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PSORIASIS; PUSTULAR PSORIASIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; REVIEW; SEBUM SECRETION; SIDE EFFECT; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SUPPURATIVE HIDRADENITIS; TESTOSTERONE BLOOD LEVEL; THORAX PAIN; VOMITING; WEAKNESS; XANTHOMA;

HUMANS; METFORMIN; SKIN DISEASES;

EID: 84886880548     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12116     Document Type: Review

References (46)

1. Kirpichnikov D, McFarlane SI, Sowers JR,. Metformin: an update. Ann Intern Med 2002; 137: 25-33.
2. Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F,. Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) 2012; 122: 253-270.
3. Bo S, Benso A, Durazzo M, Ghigo E,. Does use of metformin protect against cancer in Type 2 diabetes mellitus? J Endocrinol Invest 2012; 35: 231-235.
4. Del Barco S, Vazquez-Martin A, Cufí S, et al,. Metformin: multi-faceted protection against cancer. Oncotarget. 2011; 2: 896-917.
5. Dolasbox drawings light down and leftk I, Sener SY, Celebbox drawings light down and left K, Aydbox drawings light down and leftn ZM, Korkmaz U, Canturk Z,. The effect of metformin on mean platelet volume in dbox drawings light down and leftabetbox drawings light down and leftc patients. Platelets. 2013; 24: 118-121.
6. Grant PJ,. Beneficial effects of metformin on haemostasis and vascular function in man. Diabetes Metab 2003; 29: 6S44-6S52.
7. Knowler WC, Barrett-Connor E, Fowler SE, et al,.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
8. DeFronzo RA,. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999; 131: 281-303.
9. Brodell LA, Mercurio MG,. Hirsutism: diagnosis and management. Gend Med 2010; 7: 79-87.
10. Teede H, Deeks A, Moran L,. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010; 8: 41-50.
11. Weickert MO, Hodges P, Tan BK, Randeva HS,. Neuroendocrine and endocrine dysfunction in the hyperinsulinemic PCOS patient: the role of metformin. Minerva Endocrinol 2012; 37: 25-40.
12. Harborne L, Fleming R, Lyall H, Sattar N, Norman J,. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 4116-4123.
13. Kelly CJ, Gordon D,. The effect of metformin on hirsutism in polycystic ovary syndrome. Eur J Endocrinol 2002; 147: 217-221.
14. Ibáñez L, Lõpez-Bermejo A, Díaz M, Marcos MV, de Zegher F,. Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence. J Clin Endocrinol Metab 2011; 96: E1262-E1267.
15. Rezvanian H, Adibi N, Siavash M, Kachuei A, Shojaee-Moradie F, Asilian A,. Increased insulin sensitivity by metformin enhances intense-pulsed-light- assisted hair removal in patients with polycystic ovary syndrome. Dermatology 2009; 218: 231-236.
16. Pawin H, Beylot C, Chivot M, et al,. Physiopathology of acne vulgaris: recent data, new understanding of the treatments. Eur J Dermatol 2004; 14: 4-12.
17. Bergstrom KG,. Everything old is new again: spironolactone and metformin in the treatment of acne. J Drugs Dermatol 2010; 9: 569-571.
18. Ibáñez L, Diaz M, Sebastiani G, et al,. Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproteroneacetate versus low-dose pioglitazone-flutamide-metformin. J Clin Endocrinol Metab 2011; 96: 3361-3366.
19. Fimmel S, Zouboulis CC,. Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinol 2010; 2: 9-16.
20. Arun B, Loffeld A,. Long-standing hidradenitis suppurativa treated effectively with metformin. Clin Exp Dermatol 2009; 34: 920-921.
21. Verdolini R, Clayton N, Smith A, Alwash N, Mannello B,. Metformin for the treatment of hidradenitis suppurativa: a little help along the way. J Eur Acad Dermatol Venereol 2012. doi: 10.1111/j.1468-3083.2012.04668.x. [Epub ahead of print].
22. Hermanns-Lê T, Scheen A, Piérard GE,. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol 2004; 5: 199-203.
23. Jensterle M, Janez A, Mlinar B, Marc J, Prezelj J, Pfeifer M,. Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome. Eur J Endocrinol 2008; 158: 793-801.
24. Pryor PR, Liu SC, Clark AE, Yang J, Holman GD, Tosh D,. Chronic insulin effects on insulin signalling and GLUT4 endocytosis are reversed by metformin. Biochem J 2000; 348: 83-91.
25. Yang J, Holman GD,. Long-term metformin treatment stimulates cardiomyocyte glucose transport through an AMP-activated protein-kinase dependent reduction in GLUT4 endocytosis. Endocrinology 2006; 147: 2728-2736.
26. Hermanns-Lê T, Hermanns JF, Piérard GE,. Juvenile acanthosis nigricans and insulin resistance. Pediatr Dermatol 2002; 19: 12-14.
27. Walling HW, Messingham M, Myers LM, Mason CL, Strauss JS,. Improvement of acanthosis nigricans on isotretinoinand metformin. J Drugs Dermatol 2003; 2: 677-681.
28. Bellot-Rojas P, Posadas-Sanchez R, Caracas-Portilla N, et al,. Comparison of metformin versus rosiglitazone in patients with Acanthosis nigricans: a pilot study. J Drugs Dermatol 2006; 5: 884-889.
29. Wasniewska M, Arrigo T, Crisafulli G, et al,. Recovery of acanthosis nigricans under prolonged metformin treatment in an adolescent with normal weight. J Endocrinol Invest 2009; 32: 939-940.
30. Brauchli YB, Jick SS, Curtin F, Meier CR,. Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: a population based case-control study. J Am Acad Dermatol 2008; 58: 421-429.
31. Babad F,. Psoriasis and phenformin hydrochloride: a report on 2 cases. J Med Soc N J 1974; 71: 412-413.
32. Koca R, Altinyazar HC, Yenidünya S, Tekin NS,. Psoriasiform drug eruption associated with metformin hydrochloride: a case report. Dermatol Online J 2003; 9: 11-12.
33. Lakshmi C, Srinivas CR, Paul S, Chitra TV, Kanchanamalai K, Somasundaram LS,. Recurrent impetigo herpetiformis with diabetes and hypoalbuminemia successfully treated with cyclosporine, albumin, insulin and metformin. Indian J Dermatol 2010; 55: 181-184.
34. Tomic T, Botton T, Cerezo M, et al,. Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. Cell Death Dis 2011; 2: e199. doi: 10.1038/cddis.2011.86.
35. Martin MJ, Hayward R, Viros A, Marais R,. Metformin accelerates the growth of BRAF V600E-driven melanoma by upregulating VEGF-A. Cancer Discov 2012; 2: 344-355.
36. Chaudhary SC, Kurundkar D, Elmets CA, Kopelovich L, Athar M,. Metformin, an antidiabetic agent reduces growth of cutaneous squamous cell carcinoma by targeting mTOR signaling pathway(†). Photochem Photobiol 2012; 88: 1149-1156.
37. Man'cheva TA, Demidov DV, Plotnikova NA, Kharitonova TV, Pashkevich IV, Anisimov VN,. Melatonin and metformin inhibit skin carcinogenesis and lipid peroxidation induced by benz(a)pyrene in female mice. Bull Exp Biol Med 2011; 151: 363-365.
38. Vitale-Cross L, Molinolo AA, Martin D, et al,. Metformin prevents the development of oral squamous cell carcinomas from carcinogen-induced premalignant lesions. Cancer Prev Res (Phila) 2012; 5: 562-573.
39. Streit E, Helmbold P,. [ 65-year-old man with yellow-orange papules on both forearms Eruptive xanthomas ]. Hautarzt 2009; 60: 834-837.
40. Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108: 1167-1174.
41. Scarpello JH, Howlett HC,. Metformin therapy and clinical uses. Diab Vasc Dis Res 2008; 5: 157-167.
42. Skandalis K, Spirova M, Gaitanis G, Tsartsarakis A, Bassukas ID,. Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin. J Eur Acad Dermatol Venereol 2012; 26: 249-253.
43. Klapholz L, Leitersdorf E, Weinrauch L,. Leucocytoclastic vasculitis and pneumonitis induced by metformin. Br Med J (Clin Res Ed) 1986; 293: 483.
44. Ben Salem C, Hmouda H, Slim R, Denguezli M, Belajouza C, Bouraoui K,. Rare case of metformin-induced leukocytoclastic vasculitis. Ann Pharmacother 2006; 40: 1685-1687.
45. Czarnowicki T, Ramot Y, Ingber A, Maly A, Horev L,. Metformin-induced leukocytoclastic vasculitis: a case report. Am J Clin Dermatol 2012; 13: 61-63.
46. Azzam H, Bergman R, Friedman-Birnbaum R,. Lichen planus associated with metformin therapy. Dermatology. 1997; 194: 376-377.